Literature DB >> 9530793

Medication use for low back pain in primary care.

D C Cherkin1, K J Wheeler, W Barlow, R A Deyo.   

Abstract

STUDY
DESIGN: A longitudinal observational study of primary care patients with low back pain.
OBJECTIVES: 1) To describe medications prescribed for back pain, 2) to identify patient characteristics associated with type of drug therapy, 3) to determine if the prescription of certain drugs is associated with better outcomes, and 4) to compare physician prescribing behavior with national guidelines. SUMMARY OF BACKGROUND DATA: Few previous studies have focused on medication prescribing patterns for back pain in primary care.
METHODS: Two-hundred nineteen patients aged 20-69 years who were making a first visit for an episode of back pain were studied. After the visit, patients completed questionnaires regarding sociodemographic characteristics, health status, back pain experience, and use of medications. Symptom severity and dysfunction were assessed by telephone 1 week after the visit.
RESULTS: Sixty-nine percent of patients were prescribed nonsteroidal anti-inflammatory drugs, 35% muscle relaxants, 12% narcotics, and 4% acetaminophen. Twenty percent received no medications. Patients were more likely to receive medications if they had a desire for medication, pain below the knee, less than 3 weeks of pain before visit, more severe symptoms, or greater dysfunction. Patients with more severe symptoms were more likely to receive narcotics or muscle relaxants. Patients with greater dysfunction were also more likely to receive narcotics. Type of drug therapy predicted symptom severity but not dysfunction after 1 week. Controlling for other factors, those receiving medications had less severe symptoms after 1 week than patients who received no medication. Patients receiving both muscle relaxants and nonsteroidal anti-inflammatory drugs had the best outcomes. Medication use for back pain in this health maintenance organization was generally concordant with national guidelines.
CONCLUSIONS: Nonsteroidal anti-inflammatory drugs, often augmented by muscle relaxants, are a standard medical treatment for back pain in primary care. In this observational study, patients prescribed medications, particularly muscle relaxants, reported less severe symptoms after 1 week than those receiving no medications. However, randomized trials are needed to determine which medication or combinations of medications are most effective.

Entities:  

Mesh:

Substances:

Year:  1998        PMID: 9530793     DOI: 10.1097/00007632-199803010-00015

Source DB:  PubMed          Journal:  Spine (Phila Pa 1976)        ISSN: 0362-2436            Impact factor:   3.468


  25 in total

1.  Bioavailability of oral carisoprodol 250 and 350 mg and metabolism to meprobamate: A single-dose crossover study.

Authors:  Steve Simon; Carrie D'Andrea; William J Wheeler; Harry Sacks
Journal:  Curr Ther Res Clin Exp       Date:  2010-02

2.  What types of degenerative lumbar pathologies respond to nerve root injection? A retrospective review of six hundred and forty one cases.

Authors:  Masahiro Kanayama; Fumihiro Oha; Tomoyuki Hashimoto
Journal:  Int Orthop       Date:  2015-04-16       Impact factor: 3.075

Review 3.  Mechanical low back pain--a rheumatologist's view.

Authors:  David Borenstein
Journal:  Nat Rev Rheumatol       Date:  2013-09-10       Impact factor: 20.543

Review 4.  Evaluating and managing acute low back pain in the primary care setting.

Authors:  S J Atlas; R A Deyo
Journal:  J Gen Intern Med       Date:  2001-02       Impact factor: 5.128

Review 5.  Pharmacological management of low back pain.

Authors:  Roger Chou
Journal:  Drugs       Date:  2010-03-05       Impact factor: 9.546

6.  Ten-year survey reveals differences in GP management of neck and back pain.

Authors:  Zoe A Michaleff; Christopher Harrison; Helena Britt; Chung-Wei Christine Lin; Chris G Maher
Journal:  Eur Spine J       Date:  2012-01-08       Impact factor: 3.134

7.  Reduction of chronic non-specific low back pain: a randomised controlled clinical trial on acupuncture and baclofen.

Authors:  Jalal Zaringhalam; Homa Manaheji; Ali Rastqar; Maryam Zaringhalam
Journal:  Chin Med       Date:  2010-04-24       Impact factor: 5.455

8.  Narcotic drug use among patients with lower back pain in employer health plans: a retrospective analysis of risk factors and health care services.

Authors:  YongJoo Rhee; Michael S Taitel; David R Walker; Denys T Lau
Journal:  Clin Ther       Date:  2007       Impact factor: 3.393

9.  Aceclofenac-tizanidine in the treatment of acute low back pain: a double-blind, double-dummy, randomized, multicentric, comparative study against aceclofenac alone.

Authors:  Anil Pareek; Nitin Chandurkar; A S Chandanwale; Ratnakar Ambade; Anil Gupta; Girish Bartakke
Journal:  Eur Spine J       Date:  2009-05-07       Impact factor: 3.134

10.  Outcomes of a group education/exercise intervention in a population of patients with non-specific low back pain: a 3-year review.

Authors:  S Murphy; C Blake; C K Power; B M Fullen
Journal:  Ir J Med Sci       Date:  2013-09-15       Impact factor: 1.568

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.